[1] Tan Y, Wang Z, Xu M, et al.Oral squamous cell carcinomas: state of the field and emerging directions[J]. Int J Oral Sci, 2023, 15(1): 44-45. [2] Ren ZH, Liu K, Chen Y, et al.Prospective observational study of surgery alone for locally advanced oral squamous cell carcinoma: a real-world study[J]. BMC Oral Health, 2024, 24(1): 156-157. [3] Li H, Zhang Y, Xu M, et al.Current trends of targeted therapy for oral squamous cell carcinoma[J]. J Cancer Res Clin Oncol, 2022, 148(9): 2169-2186. [4] Niu Q, Sun Q, Bai R, et al.Progress of nanomaterials-based photothermal therapy for oral squamous cell carcinoma[J]. Int J Mol Sci, 2022, 23(18): 10428-10429. [5] Yin Q, Zhang J, Zhang H, et al.Cascade nanoreactor employs mitochondrial-directed chemodynamic and δ-ALA-mediated photodynamic synergy for deep-seated oral cancer therapy[J]. Adv Healthc Mater, 2024, 13(19): e2304639-e2304640. [6] Ran J, Liu T, Song C, et al.Rhythm mild-temperature photothermal therapy enhancing immunogenic cell death response in oral squamous cell carcinoma[J]. Adv Healthc Mater, 2023, 12(6): e2202360-e2202361. [7] Mcilvanna E, Linden GJ, Craig SG, et al.Fusobacterium nucleatum and oral cancer: a critical review[J]. BMC Cancer, 2021, 21(1): 1212-1213. [8] Wang S, Song A, Xie J, et al.Fn-OMV potentiates ZBP1-mediated PANoptosis triggered by oncolytic HSV-1 to fuel antitumor immunity[J]. Nat Commun, 2024, 15(1): 3669-3670. [9] Du C, Wu X, He M, et al.Polymeric photothermal agents for cancer therapy: recent progress and clinical potential[J]. J Mat Chem B, 2021, 9(6): 1478-1490. [10] Li Z, Lai X, Fu S, et al.Immunogenic Cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency[J]. Adv Sci (Weinh), 2022, 9(22): e2201734-e2201735. [11] Ahmed A, Tait SWG.Targeting immunogenic cell death in cancer[J]. Mol Oncol, 2020, 14(12): 2994-3006. [12] Fucikova J, Kepp O, Kasikova L, et al.Detection of immunogenic cell death and its relevance for cancer therapy[J]. Cell Death Dis, 2020, 11(11): 1013-1014. [13] Sun J, Tang Q, Yu S, et al.F.nucleatum facilitates oral squamous cell carcinoma progression via GLUT1-driven lactate production[J]. EBioMedicine, 2023, 88: 104444-104445. [14] Zheng R, Ma J.Immunotherapeutic implications of toll-like receptors activation in tumor microenvironment[J]. Pharmaceutics, 2022, 14(11): 2285. |